PETALING JAYA: Pharmaniaga Bhd
expects a well-executed turnaround despite the current challenges as it continues to focus on its strategic positioning and potential.
In a filing with Bursa Malaysia, the Practice Note 17-classified pharmaceutical group said it is preparing a comprehensive regulation plan to be submitted to Bursa Malaysia by the third quarter of 2023, and expects the initiative to be finalised by the first quarter of next year.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
